Coldstream Capital Management Inc Spring Works Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,666 shares of SWTX stock, worth $123,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,666Holding current value
$123,249% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
288Shares Held
64.2MCall Options Held
3.47MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA7.08MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$260 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$135 Million0.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx2.89MShares$134 Million2.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$119 Million0.01% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.88B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...